Page 6 - Read Online
P. 6

Page 2 of 3                Aronson et al. Hepatoma Res 2022;8:22  https://dx.doi.org/10.20517/2394-5079.2022.20

                                                                               [8]
               allowed to establish a new universal risk stratification system for HB . Concomitant international
               collaboration of pediatric pathologists made it possible to use the collected data to establish a new
               international histopathologic consensus classification for pediatric liver tumors as a whole, with particular
               focus on the histological subtypes of HB [9,10] .


               During the same period, advances in chemotherapy options developed, an increased role of liver
               transplantation for unresectable tumors was established, and a web portal system was created at
               www.siopel.org for international education, consultation, and collaboration. These achievements are
               currently further tested and validated in the running Paediatric Hepatic International Tumour Trial
               (PHITT).


               This small collection of papers on this subject invites the interested reader to further explore the existing
               literature on the achievements in the field of Pediatric Liver Tumors that have been established during the
               past decades .
                          [11]

               DECLARATIONS
               Authors’ contributions
               Editorial written: Aronson DC
               Suggestions and changes added: Czauderna P

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2022.


               REFERENCES
               1.       Armengol C, Cairo S, Kappler R. Bridging molecular basis, prognosis, and treatment of pediatric liver tumors. Hepatoma Res
                   2021;7:50.  DOI
               2.       Kościuszko D, Niemirycz-Makurat A, Anzelewicz S, Gołębiewski A, Czauderna P. Preoperative planning in paediatric liver tumour
                   surgery - a literature review. Hepatoma Res 2021;7:51.  DOI
               3.       Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Kurihara S, Kojima M, Saeki I, Inoue T, Tanaka Y. The prognostic evaluation of
                   marginal positive resection in hepatoblastoma: Japanese experience. Hepatoma Res 2021;7:44.  DOI
               4.       Calinescu AM, Héry G, Goyet JV, Branchereau S. A practical approach to pediatric liver transplantation in hepatoblastoma and
                   hepatocellular carcinoma. Hepatoma Res 2021;7:59.  DOI
               5.       Weeda VB, Murawski M. The future of pediatric hepatocellular carcinoma: a combination of surgical, locoregional, and targeted
                   therapy. Hepatoma Res 2021;7:43.  DOI
               6.       Calinescu AM, Wildhaber BE, Guérin F. Surgical perspective on treatment of pediatric undifferentiated sarcoma of the liver.
   1   2   3   4   5   6   7   8   9   10   11